Organization · Accelerator
Sera Medicines, LLC
Sera Medicines, LLC is a biologics-focused accelerator based in New Jersey that specializes in advancing and spinning out companies developing next-generation protein therapeutics.
Overview
What Sera Medicines, LLC does
What Sera Medicines, LLC is
Sera Medicines, LLC is a biologics-focused accelerator based in New Jersey that specializes in advancing and spinning out companies developing next-generation protein therapeutics.
How it participates in the startup ecosystem
The current public profile supports funder and program host capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Accelerator
- Founded
- Founded in 2023
- Approximate age
- About 3 years
- Structured capabilities
- Funder · Program host
- Last reviewed
- April 11, 2026
What Accelerator means
An accelerator is a structured, short-term program designed to speed up a startup's progress toward product-market fit, traction, fundraising, or scale.
Open the glossary entryOfficial channels
Find Sera Medicines, LLC elsewhere
Open the official website or a supported primary organization account.
Capability profile
Sera Medicines, LLC as a funder
Investment thesis
Sera Medicines, LLC focuses on advancing next-generation protein therapeutics to treat complex diseases with significant unmet medical needs.
Focus narrative
Sera Medicines invests in and develops biologics-focused therapies, emphasizing the creation of protein therapeutics that address complex diseases. Their approach includes incubating programs that achieve key value inflection points, leading to the formation of spinout companies.
Focus and fit
- Stages
- Accelerator
- Regions
- United States
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 2
Portfolio context
Notable spinouts from Sera Medicines include Tenet Medicines, which focuses on developing innovative therapies, and Navigator Medicines, which engages in the development of bispecific antibody therapeutics for autoimmune diseases.
Capability profile
Sera Medicines, LLC as a program host
Program thesis
Sera Medicines, LLC is a biologics-focused accelerator specializing in advancing next-generation protein therapeutics aimed at treating complex diseases with significant unmet medical needs.
Focus narrative
Sera Medicines invests in and develops biologics-focused therapies. The organization emphasizes the creation of protein therapeutics that address complex diseases. Their approach includes incubating programs that achieve key value inflection points, leading to the formation of spinout companies.
Availability
- Application state
- Not published
Focus and fit
- Stages
- Accelerator
- Sectors
- Biotech & Life Sciences
- Regions
- United States
Alumni and track record
Alumni context
Notable spinouts from Sera Medicines include Tenet Medicines, which focuses on developing innovative therapies, and Navigator Medicines, which engages in the development of bispecific antibody therapeutics for autoimmune diseases.
Common questions
What to know about Sera Medicines, LLC
Upseed classifies Sera Medicines, LLC under the Accelerator organization type. Its current public profile includes funder and program host capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 11, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.